Clearmind Medicine Current Ratio vs. Net Income
| CMND Stock | USD 1.33 0.10 6.99% |
Current Ratio | First Reported 2010-12-31 | Previous Quarter 1.33 | Current Value 1.27 | Quarterly Volatility 6.90025012 |
For Clearmind Medicine profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Clearmind Medicine to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Clearmind Medicine Common utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Clearmind Medicine's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Clearmind Medicine Common over time as well as its relative position and ranking within its peers.
Clearmind |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearmind Medicine. If investors know Clearmind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearmind Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.23) | Return On Assets (0.58) | Return On Equity (2.68) |
The market value of Clearmind Medicine Common is measured differently than its book value, which is the value of Clearmind that is recorded on the company's balance sheet. Investors also form their own opinion of Clearmind Medicine's value that differs from its market value or its book value, called intrinsic value, which is Clearmind Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearmind Medicine's market value can be influenced by many factors that don't directly affect Clearmind Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearmind Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearmind Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearmind Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Clearmind Medicine Common Net Income vs. Current Ratio Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Clearmind Medicine's current stock value. Our valuation model uses many indicators to compare Clearmind Medicine value to that of its competitors to determine the firm's financial worth. Clearmind Medicine Common is rated below average in current ratio category among its peers. It is rated second in net income category among its peers . At present, Clearmind Medicine's Current Ratio is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Clearmind Medicine by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Clearmind Net Income vs. Current Ratio
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Clearmind Medicine |
| = | 0.03 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Clearmind Medicine |
| = | (6.23 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Clearmind Net Income Comparison
Clearmind Medicine is currently under evaluation in net income category among its peers.
Clearmind Medicine Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Clearmind Medicine, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Clearmind Medicine will eventually generate negative long term returns. The profitability progress is the general direction of Clearmind Medicine's change in net profit over the period of time. It can combine multiple indicators of Clearmind Medicine, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -17.7 K | -16.8 K | |
| Operating Income | -7.9 M | -7.5 M | |
| Net Loss | -7.8 M | -7.4 M | |
| Income Before Tax | -10.7 M | -10.2 M | |
| Total Other Income Expense Net | -2.9 M | -2.7 M | |
| Net Loss | -8.5 M | -8 M | |
| Net Loss | -5.6 M | -5.3 M | |
| Income Tax Expense | 27.7 K | 29.1 K | |
| Net Interest Income | 68.1 K | 71.5 K | |
| Change To Netincome | 2.9 M | 3 M | |
| Net Loss | (68.06) | (71.46) | |
| Income Quality | 0.84 | 0.89 | |
| Net Income Per E B T | 1.15 | 1.12 |
Clearmind Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Clearmind Medicine. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Clearmind Medicine position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Clearmind Medicine's important profitability drivers and their relationship over time.
Use Clearmind Medicine in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Clearmind Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearmind Medicine will appreciate offsetting losses from the drop in the long position's value.Clearmind Medicine Pair Trading
Clearmind Medicine Common Pair Trading Analysis
The ability to find closely correlated positions to Clearmind Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Clearmind Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Clearmind Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Clearmind Medicine Common to buy it.
The correlation of Clearmind Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Clearmind Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Clearmind Medicine Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Clearmind Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Clearmind Medicine position
In addition to having Clearmind Medicine in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cancer Fighters Thematic Idea Now
Cancer Fighters
Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases. The Cancer Fighters theme has 60 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cancer Fighters Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
To fully project Clearmind Medicine's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Clearmind Medicine Common at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Clearmind Medicine's income statement, its balance sheet, and the statement of cash flows.